FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034672341> ?p ?o ?g. }

• W2034672341 endingPage "510" @default.
• W2034672341 startingPage "497" @default.
• W2034672341 abstract "LY207702 (1) is a difluorinated purine nucleoside that exhibits impressive antitumor activity in preclinical models. This agent, however, also possesses cardiotoxicity which limits the potential clinical utility of this novel drug candidate. We therefore developed linker chemistry whereby regioselective N6-tritylation of LY207702 (1) allowed this drug to be coupled to ε-lysine amino groups of mAb's reactive with human tumor-associated antigens. The resulting immunoconjugates 3 possessed conjugation ratios ranging from 5 to 7 mol of LY207702/mol of mAb, minimal aggregate content (5−10%), and good immunoreactivity. The electronic nature of substituents on the aromatic rings of the trityl group dictated the degree of acid lability of the trityl linker. Increased electronic stabilization of the transient trityl carbocation led to increase in the release rate of free drug, i.e., m-DMT 10a = p-DMT 10b > p-MMT 10d > p-T 10f. Consequently, the more acid labile DMT conjugates 3a and 3b proved to be the most potent cytotoxic agents, and the most stable p-T conjugate 3f exhibited the least antitumor activity when evaluated in vitro and in vivo. p-MeT-linked conjugate 3e, the most stable construct that retained excellent in vivo antitumor activity, was selected for more extensive evaluation. No detectable free drug or metabolite was observed in mouse plasma at a single intravenous dose of p-MeT conjugate 3e, which was consistent with its predicted stability under physiological conditions. This construct did, however, exhibit significant antigen-mediated antitumor activity in vivo. No cardiotoxicity was detected in mice dosed with conjugate 3e (6 mg/kg free drug content per day for 21 days) equivalent to ∼8 times the total dose required for complete regression of well-established (∼1 g) HC1 human colon tumor xenografts in nude mice. Cardiotoxicity was induced in 20% of free drug 1 treated group at the equivalent dose. Cardiomyopathy was, however, observed when the dose of conjugate 3e was increased to 8 mg/kg per day for 21 days. These data suggest that antitumor activity of LY207702 (1) was maintained and its cardiotoxic potential reduced when this agent was administered to human tumor xenograft bearing nude mice as COL1−N6-p-MeT-207702 conjugate 3e." @default.
• W2034672341 created "2016-06-24" @default.
• W2034672341 creator A5037324253 @default.
• W2034672341 creator A5044235434 @default.
• W2034672341 creator A5054162807 @default.
• W2034672341 creator A5058781623 @default.
• W2034672341 creator A5078718914 @default.
• W2034672341 creator A5084524088 @default.
• W2034672341 creator A5086365093 @default.
• W2034672341 creator A5091092099 @default.
• W2034672341 date "1996-01-01" @default.
• W2034672341 modified "2023-09-27" @default.
• W2034672341 title "Novel Acid Labile COL1 Trityl-Linked Difluoronucleoside Immunoconjugates: Synthesis, Characterization, and Biological Activity¹" @default.
• W2034672341 cites W1811830539 @default.
• W2034672341 cites W1988777429 @default.
• W2034672341 cites W1990910469 @default.
• W2034672341 cites W1998350878 @default.
• W2034672341 cites W2017501021 @default.
• W2034672341 cites W2043392146 @default.
• W2034672341 cites W2048567466 @default.
• W2034672341 cites W2049197278 @default.
• W2034672341 cites W2056223219 @default.
• W2034672341 cites W2069607377 @default.
• W2034672341 cites W2321142293 @default.
• W2034672341 doi "https://doi.org/10.1021/bc960038u" @default.
• W2034672341 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8853464" @default.
• W2034672341 hasPublicationYear "1996" @default.
• W2034672341 type Work @default.
• W2034672341 sameAs 2034672341 @default.
• W2034672341 citedByCount "35" @default.
• W2034672341 countsByYear W20346723412012 @default.
• W2034672341 countsByYear W20346723412013 @default.
• W2034672341 countsByYear W20346723412014 @default.
• W2034672341 countsByYear W20346723412016 @default.
• W2034672341 countsByYear W20346723412017 @default.
• W2034672341 countsByYear W20346723412020 @default.
• W2034672341 countsByYear W20346723412022 @default.
• W2034672341 crossrefType "journal-article" @default.
• W2034672341 hasAuthorship W2034672341A5037324253 @default.
• W2034672341 hasAuthorship W2034672341A5044235434 @default.
• W2034672341 hasAuthorship W2034672341A5054162807 @default.
• W2034672341 hasAuthorship W2034672341A5058781623 @default.
• W2034672341 hasAuthorship W2034672341A5078718914 @default.
• W2034672341 hasAuthorship W2034672341A5084524088 @default.
• W2034672341 hasAuthorship W2034672341A5086365093 @default.
• W2034672341 hasAuthorship W2034672341A5091092099 @default.
• W2034672341 hasConcept C111919701 @default.
• W2034672341 hasConcept C134306372 @default.
• W2034672341 hasConcept C150903083 @default.
• W2034672341 hasConcept C185592680 @default.
• W2034672341 hasConcept C197336794 @default.
• W2034672341 hasConcept C202751555 @default.
• W2034672341 hasConcept C207001950 @default.
• W2034672341 hasConcept C2776016237 @default.
• W2034672341 hasConcept C2777477808 @default.
• W2034672341 hasConcept C2780557392 @default.
• W2034672341 hasConcept C33923547 @default.
• W2034672341 hasConcept C41008148 @default.
• W2034672341 hasConcept C515207424 @default.
• W2034672341 hasConcept C55493867 @default.
• W2034672341 hasConcept C71240020 @default.
• W2034672341 hasConcept C86803240 @default.
• W2034672341 hasConceptScore W2034672341C111919701 @default.
• W2034672341 hasConceptScore W2034672341C134306372 @default.
• W2034672341 hasConceptScore W2034672341C150903083 @default.
• W2034672341 hasConceptScore W2034672341C185592680 @default.
• W2034672341 hasConceptScore W2034672341C197336794 @default.
• W2034672341 hasConceptScore W2034672341C202751555 @default.
• W2034672341 hasConceptScore W2034672341C207001950 @default.
• W2034672341 hasConceptScore W2034672341C2776016237 @default.
• W2034672341 hasConceptScore W2034672341C2777477808 @default.
• W2034672341 hasConceptScore W2034672341C2780557392 @default.
• W2034672341 hasConceptScore W2034672341C33923547 @default.
• W2034672341 hasConceptScore W2034672341C41008148 @default.
• W2034672341 hasConceptScore W2034672341C515207424 @default.
• W2034672341 hasConceptScore W2034672341C55493867 @default.
• W2034672341 hasConceptScore W2034672341C71240020 @default.
• W2034672341 hasConceptScore W2034672341C86803240 @default.
• W2034672341 hasIssue "4" @default.
• W2034672341 hasLocation W20346723411 @default.
• W2034672341 hasLocation W20346723412 @default.
• W2034672341 hasOpenAccess W2034672341 @default.
• W2034672341 hasPrimaryLocation W20346723411 @default.
• W2034672341 hasRelatedWork W1963940212 @default.
• W2034672341 hasRelatedWork W1989672218 @default.
• W2034672341 hasRelatedWork W2035747340 @default.
• W2034672341 hasRelatedWork W2095688968 @default.
• W2034672341 hasRelatedWork W2112999176 @default.
• W2034672341 hasRelatedWork W2156678100 @default.
• W2034672341 hasRelatedWork W2959843262 @default.
• W2034672341 hasRelatedWork W3025552567 @default.
• W2034672341 hasRelatedWork W4286914113 @default.
• W2034672341 hasRelatedWork W4294301069 @default.
• W2034672341 hasVolume "7" @default.
• W2034672341 isParatext "false" @default.
• W2034672341 isRetracted "false" @default.
• W2034672341 magId "2034672341" @default.
• W2034672341 workType "article" @default.